The American Cancer Society, the nation’s largest non-governmental funder of cancer research, has given its highest award, the Medal of Honor, to four Americans who have made outstanding contributions to the fight against cancer. Among the honorees is Susan Band Horwitz, Ph.D., distinguished professor and co-chair of the Department of Molecular Pharmacology at Albert Einstein College of Medicine of Yeshiva University, who is recognized for her groundbreaking research on the cancer drug Taxol (paclitaxel), which has been used by more than 1 million patients around the world to treat cancers of the ovary, breast and lung.
A groundbreaking conference on “Talking About Intimacy: The Rabbi’s Role,” cosponsored by Yeshiva University’s Center for the Jewish Future (CJF), Tzelem, and the Rabbinical Council of America, was recently held at Yeshiva University (YU). More than 100 rabbis attended the gathering, which addressed issues of intimacy according to halakhah (Jewish law). Tzelem, an incubator project of CJF, organized the event to educate and empower communal rabbis in responding to their congregants’ needs about issues of intimacy.
Yeshiva University will break ground on Monday, September 18 at 6:30 pm for The Jacob and Dreizel Glueck Center for Jewish Study and The Jacob and Dreizel Glueck Beit Midrash—the university’s first new building at the Wilf Campus since the Max Stern Athletic Center in 1983. Festivities will take place at the construction site (the former Parking Lot “A” at 185th Street, directly across from Furst Hall).